INPP5D
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1
As of the edition of 20 October 2026, INPP5D (phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1, UniProt Q92835) has 1 drug tested at it and 1 company on the list, 1 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- Q92835
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Where it sits in the cell
- In more than one place
- Solved structures
- 99
- Disease areas
- Pregnancy and women's health; Urinary and reproductive; Immune system; Inherited and neonatal; Lungs and airways; Skin and connective tissue
- Registered trials of its drugs
- 7
Drugs at this target
| Status | Count |
|---|---|
| Went quiet | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Rosiptor | Went quiet | Phase 3 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 1 |
| Total on the list | 1 |
| Company | Route |
|---|---|
| Aquinox Pharmaceuticals | Route A |
The other 0 companies at INPP5D
In the product1 company in all; 0 are not named here, and no score is.
See the 1 companies at INPP5D, ranked, with the facts behind eachRequest access. Nothing is shown until you do.